OCUSERT PILO-40 pharmaceutical API fine chemical sources

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Molport	⤷ Get Started Free	MolPort-002-512-506	⤷ Get Started Free
TimTec	⤷ Get Started Free	ST069319	⤷ Get Started Free
TimTec	⤷ Get Started Free	SBB012409	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 1, 2025

Introduction

The market for controlled-release formulations, such as the OCUSERT Pilo-40, hinges on the availability of high-quality active pharmaceutical ingredients (APIs). OCUSERT Pilo-40 is a sustained-release ocular insert containing pilocarpine nitrate, used primarily to treat glaucoma and ocular hypertension by inducing miosis and lowering intraocular pressure. Ensuring a reliable supply chain for the pilocarpine API is vital for manufacturers aiming to produce consistent, effective ophthalmic products. This report delineates the primary sources, manufacturers, and procurement considerations for pilocarpine API, tailored for companies interested in developing or maintaining OCUSERT Pilo-40 production.

Overview of Pilocarpine API

Pilocarpine nitrate, an alkaloid derived mainly from the Pilocarpus jaborandi plant, is a cholinergic agonist used in traditional and modern formulations for glaucoma management. The API is synthesized via either natural extraction or synthetic routes, with the latter increasingly preferred due to scalability, consistency, and purity considerations. The quality standards for ophthalmic APIs, especially those used in controlled-release devices, demand stringent adherence to pharmacopeial specifications, including purity (>99%), low residual solvents, and impurity profiles.

Primary API Manufacturers for Pilocarpine

1. Major Global API Suppliers

a. Sun Pharmaceutical Industries Ltd.

Overview: A leading Indian pharmaceutical company with extensive API manufacturing capabilities.
API Production: Supplies high-purity pilocarpine nitrate suitable for ophthalmic applications.
Certifications: WHO-GMP, USFDA, EDQM-approved facilities.
Supply Security: Long-standing track record of consistent supply for ophthalmic APIs.

b. OPHTHARMA LLC

Overview: A prominent manufacturer specializing in ophthalmic API synthesis.
API Specifications: Focuses on high purity pilocarpine nitrate tailored for sterile ophthalmic formulations.
Quality Assurance: Complies with international pharmacopeia standards, with dedicated quality control labs.

c. Carbosynth

Overview: A global supplier of fine chemicals and research reagents, with specialized ophthalmic API offerings.
API Quality: Offers pharmaceutical-grade pilocarpine nitrate with documented batch-to-batch consistency.
Certifications: CGMP compliant manufacturing.

d. Tocris Bioscience (Bio-Techne)

Overview: Offers research-grade pilocarpine with potential for custom synthesis at pharmaceutical purity levels.
Application: Mostly targeted for research but capable of scaling to GMP-grade production upon request.

2. Regional and Emerging API Suppliers

a. Indian API Manufacturing Sector

India remains a dominant supplier of pilocarpine APIs due to cost competitiveness and robust pharmaceutical infrastructure.

Key Players:
- Aurobindo Pharma
- Lupin Limited
- Hetero Labs
- Cipla Limited

These manufacturers have scaled production for both generic and branded ophthalmic APIs, often with existing certifications aligning with EPA, FDA, or EDQM standards.

b. Chinese API Producers

China hosts several GMP-compliant API manufacturers capable of producing pilocarpine nitrate at scale, including:

Zhejiang Medicine Co.
Shandong Xinhua Pharmaceutical

However, buyers should conduct rigorous due diligence on quality control processes and certification status due to regional variability.

3. Contract Manufacturing Opportunities

For companies seeking bespoke APIs or supply chain flexibility, contract manufacturing organizations (CMOs) present strategic options:

Eurofins Scientific offers custom synthesis and quality validation services for pharmaceutical APIs, including pilocarpine nitrate.
Patheon (a part of Thermo Fisher Scientific) can produce GMP APIs tailored for ophthalmic formulations.
Recipharm provides API development and manufacturing, including complex alkaloids such as pilocarpine.

Leveraging these CMOs allows for guaranteed quality, training in specific API specifications, and scalable supply.

4. Procurement Considerations for API Sourcing

a. Quality and Compliance

Given the sensitive nature of ophthalmic APIs, procurement must prioritize suppliers with:

GMP certification from recognized authorities (FDA, EDQM, local health agencies).
Validated analytical data confirming purity, impurity profiles, and stability.
Batch consistency and traceability.

b. Supply Chain Security

Ensuring reliable supply involves assessing:

Production capacity relative to demand.
Delivery timelines and logistical robustness.
Inventory management and risk mitigation (dual sourcing, stockpiling).

c. Cost Implications

While high-purity APIs come at a premium, volume discounts and long-term contractual arrangements can optimize costs. Balancing quality and price is critical, especially since ophthalmic APIs require rigorous standards.

d. Regulatory Documentation

Sourcing from suppliers with comprehensive documentation, such as Certificate of Analysis (CoA), Certificate of Pharmaceutical Product (CPP), and stability data, facilitates regulatory submissions and quality audits.

5. Future Trends and Innovation in API Sourcing

Synthetic Route Optimization: Advances in synthesis could reduce dependence on natural extraction, leading to more predictable supply.
Bioengineered API Production: Genetic engineering may produce pilocarpine variants, potentially easing sourcing constraints.
Supply Chain Transparency: Blockchain and digital tracking are increasingly employed to ensure API authenticity and integrity.

Conclusion

The procurement of pilocarpine API for OCUSERT Pilo-40 production necessitates sourcing from established, high-quality API manufacturers with global regulatory recognition. Indian pharmaceutical giants like Sun Pharma and regional Chinese suppliers remain key providers, with numerous CMOs offering tailored production services. Rigorous due diligence to ensure GMP compliance, lot-to-lot consistency, and regulatory validity is non-negotiable for maintaining product efficacy and safety in ophthalmic applications. Strategic supplier relationships, combined with robust supply chain management, underpin successful manufacturing of ophthalmic controlled-release systems.

Key Takeaways

Main sourcing hubs: India and China dominate pilocarpine API supply, with leading manufacturers offering GMP-compliant products.
Quality assurance: Stringent adherence to pharmacopeial standards and regulatory certifications is essential.
Supply chain management: Securing reliable, scalable, and traceable API sources minimizes production disruptions.
Partnerships with CMOs: Contract manufacturing can provide customized, validated APIs tailored for ophthalmic applications.
Future readiness: Emerging synthesis techniques and digital supply chain innovations are poised to optimize API sourcing strategies.

FAQs

1. What are the primary qualities to look for in a pilocarpine API supplier?
Suppliers should have GMP certification, comprehensive analytical validation, consistent batch quality, and proven regulatory compliance per international standards.

2. Is natural extraction of pilocarpine still prevalent for APIs used in OCUSERT Pilo-40?
Natural extraction exists but is less favored due to variability and scalability challenges. Synthetic routes dominate commercial production for consistency and efficiency.

3. How does API purity affect the performance of OCUSERT Pilo-40?
High API purity (>99%) ensures safety, minimizes adverse reactions, and guarantees consistent drug release profiles critical for ophthalmic devices.

4. Can I source pilocarpine API from regional suppliers with limited regulatory certifications?
While possible, it increases regulatory & quality risks. It is advisable to select suppliers with recognized certifications to facilitate regulatory approval and ensure product efficacy.

5. What role do contract manufacturers play in sourcing pilocarpine API?
CMOs offer custom synthesis, validation, and scalable production, enabling manufacturers to obtain APIs tailored to specific formulation needs while ensuring quality and compliance.

References:

[1] U.S. Pharmacopeia, "Pilocarpine Hydrochloride," USP Monographs.
[2] Indian Pharmaceutical Industry Overview. Pharmaceuticals Export Promotion Council of India (Pharmexcil).
[3] EDQM, "Pilocarpine Nitrate," European Pharmacopoeia Monograph.
[4] Global API Manufacturing Review, IQVIA, 2022.
[5] Contract Manufacturing in Pharmaceutical Industry, Pharma IQ, 2021.

Bulk Pharmaceutical API Sources for OCUSERT PILO-40